{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:47:23Z","timestamp":1792176443583,"version":"4.4.0"},"reference-count":47,"publisher":"American Medical Association (AMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"Importance<\/jats:title>Although cases of neonatal opioid withdrawal syndrome (NOWS) increased 5-fold in recent years, no study has examined national hospital readmission rates for these infants.<\/jats:p><\/jats:sec>Objective<\/jats:title>To examine hospital readmissions for infants with and without NOWS.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>This retrospective cohort study analyzed serial cross-sectional samples of US hospital discharge records from the Nationwide Readmissions Database for calendar years 2016 to 2020. Infants with NOWS were identified using International Classification of Diseases, Tenth Revision, Clinical Modification<\/jats:italic> codes. The data analysis was performed between January 5, 2023, and May 6, 2024.<\/jats:p><\/jats:sec>Exposure<\/jats:title>Neonatal opioid withdrawal syndrome.<\/jats:p><\/jats:sec>Main Outcome and Measures<\/jats:title>Survey-weighted logistic regression was used to examine 90-day all-cause and cause-specific hospital readmissions. Multivariable models adjusted for sex, low birth weight, gestational age, multiple gestation, type of insurance, and year of birth.<\/jats:p><\/jats:sec>Results<\/jats:title>Of the 13\u202f855\u202f246 newborns identified in this weighted analysis, 89\u202f018 (0.6%) were diagnosed with NOWS, of whom 53.8% were male and 81.1% born full-term (&amp;gt;36 weeks gestation). The 90-day all-cause readmission rate was 4.2% for infants with NOWS compared with 3.0% for those without NOWS (P<\/jats:italic>\u2009&amp;lt;\u2009.001). After risk adjustment, the odds of all-cause readmission were higher among infants with NOWS (adjusted odds ratio [AOR], 1.18; 95% CI, 1.08-1.29). Infants with NOWS had significantly higher odds of readmissions for seizures (AOR, 1.58; 95% CI, 1.01-2.46), failure to thrive (AOR, 1.99; 95% CI, 1.36-2.93), traumatic brain injury (AOR, 2.95; 95% CI, 1.76-4.93), and skull fractures (AOR 3.72; 95% CI, 2.33-5.93). Infants with NOWS had higher odds of receiving a diagnosis of confirmed maltreatment (AOR, 4.26; 95% CI, 2.19-8.27), including for neglect (AOR, 14.18; 95% CI, 5.55-36.22) and physical abuse (AOR, 2.42; 95% CI, 0.93-6.29); however, the latter finding was not statistically significant.<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>In this nationally representative cohort study, infants with NOWS were at increased risk of readmission for any cause as well as for trauma and confirmed maltreatment. These findings may in part reflect the dual stressors that mothers with opioid use disorder face in caring for a newborn with NOWS in the context of a substance use disorder and underscore the need for family-based, in-home services that focus concurrently on substance use treatment and parenting support.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2024.35074","type":"journal-article","created":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T15:00:37Z","timestamp":1727190037000},"page":"e2435074","source":"Crossref","is-referenced-by-count":11,"title":["Hospital Readmissions Among Infants With Neonatal Opioid Withdrawal Syndrome"],"prefix":"10.1001","volume":"7","author":[{"given":"Julie R.","family":"Gaither","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Yale School of Medicine, New Haven, Connecticut"},{"name":"Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Drago","sequence":"additional","affiliation":[{"name":"Division of Newborn Medicine, Icahn School of Medicine at Mount Sinai, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew R.","family":"Grossman","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Yale School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Yale School of Public Health, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"Shabanova","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Yale School of Medicine, New Haven, Connecticut"},{"name":"Department of Biostatistics, Yale School of Public Health, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Leventhal","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Yale School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2024,9,24]]},"reference":[{"issue":"18","key":"zoi241045r1","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1001\/jama.2012.3951","article-title":"Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009.","volume":"307","author":"Patrick","year":"2012","journal-title":"JAMA"},{"issue":"4","key":"zoi241045r2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2017-3520","article-title":"Incidence and costs of neonatal abstinence syndrome among infants with Medicaid: 2004-2014.","volume":"141","author":"Winkelman","year":"2018","journal-title":"Pediatrics"},{"issue":"2","key":"zoi241045r3","doi-asserted-by":"publisher","first-page":"e540","DOI":"10.1542\/peds.2011-3212","article-title":"Neonatal drug withdrawal.","volume":"129","author":"Hudak","year":"2012","journal-title":"Pediatrics"},{"issue":"8","key":"zoi241045r4","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/jp.2015.63","article-title":"Increasing incidence and geographic distribution of neonatal abstinence syndrome: United States 2009 to 2012.","volume":"35","author":"Patrick","year":"2015","journal-title":"J Perinatol"},{"issue":"2","key":"zoi241045r5","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1001\/jama.2020.24991","article-title":"Neonatal abstinence syndrome and maternal opioid-related diagnoses in the US, 2010-2017.","volume":"325","author":"Hirai","year":"2021","journal-title":"JAMA"},{"issue":"24","key":"zoi241045r6","doi-asserted-by":"publisher","first-page":"2320","DOI":"10.1056\/NEJMoa1005359","article-title":"Neonatal abstinence syndrome after methadone or buprenorphine exposure.","volume":"363","author":"Jones","year":"2010","journal-title":"N Engl J Med"},{"issue":"2","key":"zoi241045r7","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1542\/hpeds.2019-0221","article-title":"An update on the burden of neonatal abstinence syndrome in the United States.","volume":"10","author":"Ramphul","year":"2020","journal-title":"Hosp Pediatr"},{"issue":"10","key":"zoi241045r8","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1542\/hpeds.2015-0024","article-title":"Risk of hospital readmission among infants with neonatal abstinence syndrome.","volume":"5","author":"Patrick","year":"2015","journal-title":"Hosp Pediatr"},{"issue":"10","key":"zoi241045r9","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1038\/jp.2017.106","article-title":"Neonatal abstinence syndrome and early childhood morbidity and mortality in Washington state: a retrospective cohort study.","volume":"37","author":"Witt","year":"2017","journal-title":"J Perinatol"},{"issue":"9","key":"zoi241045r10","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1542\/hpeds.2021-005904","article-title":"Pediatric hospital readmissions for infants with neonatal opioid withdrawal syndrome, 2016-2019.","volume":"11","author":"Milliren","year":"2021","journal-title":"Hosp Pediatr"},{"issue":"6","key":"zoi241045r11","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2016-3360","article-title":"An initiative to improve the quality of care of infants with neonatal abstinence syndrome.","volume":"139","author":"Grossman","year":"2017","journal-title":"Pediatrics"},{"issue":"25","key":"zoi241045r12","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1056\/NEJMe2304989","article-title":"Hush little baby - promise of the eat, sleep, console approach.","volume":"388","author":"Barfield","year":"2023","journal-title":"N Engl J Med"},{"issue":"25","key":"zoi241045r13","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1056\/NEJMoa2214470","article-title":"Eat, sleep, console approach or usual care for neonatal opioid withdrawal.","volume":"388","author":"Young","year":"2023","journal-title":"N Engl J Med"},{"issue":"4","key":"zoi241045r14","doi-asserted-by":"publisher","first-page":"e811","DOI":"10.1542\/peds.2014-2767","article-title":"Reasons for rehospitalization in children who had neonatal abstinence syndrome.","volume":"136","author":"Uebel","year":"2015","journal-title":"Pediatrics"},{"issue":"2","key":"zoi241045r15","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2018-2108","article-title":"Newborn risk factors for subsequent physical abuse hospitalizations.","volume":"143","author":"Puls","year":"2019","journal-title":"Pediatrics"},{"issue":"3","key":"zoi241045r16","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1177\/1077559520930818","article-title":"Incidence of injury, maltreatment, and developmental disorders among substance exposed infants.","volume":"26","author":"Austin","year":"2021","journal-title":"Child Maltreat"},{"issue":"1","key":"zoi241045r18","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2020-007393","article-title":"Evaluating definitions for neonatal abstinence syndrome.","volume":"147","author":"Doherty","year":"2021","journal-title":"Pediatrics"},{"issue":"1","key":"zoi241045r21","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1053\/j.semperi.2006.01.007","article-title":"A recommendation for the definition of \u201clate preterm\u201d (near-term) and the birth weight-gestational age classification system.","volume":"30","author":"Engle","year":"2006","journal-title":"Semin Perinatol"},{"issue":"25","key":"zoi241045r23","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.1056\/NEJMra1600879","article-title":"Neonatal abstinence syndrome.","volume":"375","author":"McQueen","year":"2016","journal-title":"N Engl J Med"},{"issue":"3-4","key":"zoi241045r24","doi-asserted-by":"publisher","first-page":"10969","DOI":"10.1007\/s11229-021-03276-4","article-title":"When to adjust alpha during multiple testing: a consideration of disjunction, conjunction, and individual testing.","volume":"199","author":"Rubin","year":"2021","journal-title":"Synthese"},{"issue":"7","key":"zoi241045r25","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1001\/jamapediatrics.2023.1047","article-title":"Maternal opioid use disorder and the risk of postneonatal infant mortality.","volume":"177","author":"Grossarth","year":"2023","journal-title":"JAMA Pediatr"},{"issue":"2","key":"zoi241045r26","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1177\/1077559521990116","article-title":"Prenatal substance exposure and child maltreatment: a systematic review.","volume":"27","author":"Austin","year":"2022","journal-title":"Child Maltreat"},{"issue":"3-4","key":"zoi241045r27","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1080\/19371918.2013.759005","article-title":"The impact of substance use disorders on families and children: from theory to practice.","volume":"28","author":"Lander","year":"2013","journal-title":"Soc Work Public Health"},{"issue":"8","key":"zoi241045r28","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1007\/s10995-015-1689-y","article-title":"Maternal substance use and neonatal abstinence syndrome: a descriptive study.","volume":"19","author":"McQueen","year":"2015","journal-title":"Matern Child Health J"},{"key":"zoi241045r29","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.chiabu.2017.10.002","article-title":"Prenatal substance exposure diagnosed at birth and infant involvement with child protective services.","volume":"76","author":"Prindle","year":"2018","journal-title":"Child Abuse Negl"},{"issue":"1","key":"zoi241045r30","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1177\/1077559515615437","article-title":"The growing burden of neonatal opiate exposure on children and family services in Massachusetts.","volume":"21","author":"Fran\u00e7a","year":"2016","journal-title":"Child Maltreat"},{"issue":"1","key":"zoi241045r31","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2020-028340","article-title":"It is time to ACT NOW to improve quality for opioid-exposed infants.","volume":"147","author":"Patrick","year":"2021","journal-title":"Pediatrics"},{"key":"zoi241045r32","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.childyouth.2019.03.040","article-title":"Innovations in child welfare interventions for caregivers with substance use disorders and their children.","volume":"101","author":"Bosk","year":"2019","journal-title":"Child Youth Serv Rev"},{"issue":"4","key":"zoi241045r33","first-page":"161","article-title":"Family-based recovery: an innovative in-home substance abuse treatment model for families with young children.","volume":"94","author":"Hanson","year":"2015","journal-title":"Child Welfare"},{"issue":"4","key":"zoi241045r34","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.clp.2019.08.012","article-title":"Neonatal abstinence syndrome: review of epidemiology, care models, and current understanding of outcomes.","volume":"46","author":"MacMillan","year":"2019","journal-title":"Clin Perinatol"},{"issue":"6","key":"zoi241045r35","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1097\/DBP.0000000000000679","article-title":"Early intervention referral and enrollment among infants with neonatal abstinence syndrome.","volume":"40","author":"Peacock-Chambers","year":"2019","journal-title":"J Dev Behav Pediatr"},{"issue":"5","key":"zoi241045r36","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2020-029074","article-title":"Neonatal opioid withdrawal syndrome.","volume":"146","author":"Patrick","year":"2020","journal-title":"Pediatrics"},{"issue":"4","key":"zoi241045r37","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1177\/1077559520922313","article-title":"Variation in states\u2019 implementation of CAPTA\u2019s substance-exposed infants mandates: a policy diffusion analysis.","volume":"25","author":"Lloyd Sieger","year":"2020","journal-title":"Child Maltreat"},{"issue":"1","key":"zoi241045r38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1542\/hpeds.2017-0128","article-title":"A novel approach to assessing infants with neonatal abstinence syndrome.","volume":"8","author":"Grossman","year":"2018","journal-title":"Hosp Pediatr"},{"issue":"1","key":"zoi241045r39","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2020-008839","article-title":"Site-level variation in the characteristics and care of infants with neonatal opioid withdrawal.","volume":"147","author":"Young","year":"2021","journal-title":"Pediatrics"},{"issue":"1-2","key":"zoi241045r40","first-page":"141","article-title":"Neonatal abstinence syndrome: assessment and management.","volume":"2","author":"Finnegan","year":"1975","journal-title":"Addict Dis"},{"key":"zoi241045r41","first-page":"177","article-title":"Management of maternal and neonatal substance abuse problems.","volume":"90","author":"Finnegan","year":"1988","journal-title":"NIDA Res Monogr"},{"issue":"1","key":"zoi241045r44","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2017-4183","article-title":"Positive predictive value of administrative data for neonatal abstinence syndrome.","volume":"143","author":"Maalouf","year":"2019","journal-title":"Pediatrics"},{"key":"zoi241045r45","doi-asserted-by":"publisher","first-page":"i71","DOI":"10.1136\/injuryprev-2019-043513","article-title":"Accuracy of ICD-10-CM coding for physical child abuse in a paediatric level I trauma centre.","volume":"27","author":"Hughes Garza","year":"2021","journal-title":"Inj Prev"},{"issue":"10","key":"zoi241045r46","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1038\/s41372-020-0733-y","article-title":"A quality improvement initiative to implement the eat, sleep, console neonatal opioid withdrawal syndrome care tool in Massachusetts\u2019 PNQIN collaborative.","volume":"40","author":"Wachman","year":"2020","journal-title":"J Perinatol"},{"issue":"6","key":"zoi241045r47","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1001\/jamapediatrics.2024.0544","article-title":"Influence of eat, sleep, and console on infants pharmacologically treated for opioid withdrawal: a post hoc subgroup analysis of the ESC-NOW randomized clinical trial.","volume":"178","author":"Devlin","year":"2024","journal-title":"JAMA Pediatr"},{"key":"zoi241045r42","first-page":"354","article-title":"The role of stigma in the nursing care of families impacted by neonatal abstinence syndrome.","volume-title":"Adv Neonatal Care","author":"Recto","year":"2020"},{"key":"zoi241045r17","unstructured":"KID database documentation. Agency for Healthcare Research and Quality. Updated March 24, 2024. Accessed May 5, 2021. https:\/\/www.hcup-us.ahrq.gov\/db\/nation\/kid\/kiddbdocumentation.jsp"},{"key":"zoi241045r19","doi-asserted-by":"crossref","unstructured":"Patrick? SW, Barfield? WD, Poindexter? BB, . Neonatal opioid withdrawal syndrome.? Pediatrics. 2020;146(5):e2020029074. doi:10.1542\/peds.2020-029074","DOI":"10.1542\/peds.2020-029074"},{"key":"zoi241045r20","unstructured":"Neonatal opioid withdrawal syndrome and medication-assisted treatment with methadone and buprenorphine. US Food and Drug Administration. Published May 26, 2016. Accessed June 19, 2024. https:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm503630.htm."},{"key":"zoi241045r22","unstructured":"NRD Description of Data Elements: 110_DXn - ICD-10-CM diagnosis. Agency for Healthcare Research and Quality. Accessed February 7, 2024. https:\/\/hcup-us.ahrq.gov\/db\/vars\/i10_dxn\/nrdnote.jsp"},{"key":"zoi241045r43","unstructured":"Healthcare Cost and Utilization Project. Limitations on using the Nationwide Readmissions Database (NRD). Agency for Healthcare Research and Quality. Accessed June 22, 2021. https:\/\/www.hcup-us.ahrq.gov\/db\/nation\/nrd\/LimitationsonUsingtheNRD.pdf"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2823905\/gaither_2024_oi_241045_1726504332.244.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T15:00:40Z","timestamp":1727190040000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2823905"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,24]]},"references-count":47,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9,3]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.35074","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,24]]}}}